(Q61907541)

English

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

clinical trial

In more languages

Statements

0 references

Chinese PLA General Hospital Hainan Branch (English)

0 references

medical condition

0 references

atherosclerosis

0 references

1 October 2018

0 references

1 May 2019

0 references

number of participants

300

0 references

research intervention

sitagliptin phosphate

0 references

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

not yet recruiting

0 references

18 year

0 references

80 year

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61907541&oldid=2109101274"